Dr. Jane
September 17, 2022
Generation and maintenance of NPCs NPCs were generated as previously described with modifications. In detail, 80.000 iPSCs per well were plated on day − 2 on a 12-well plate, coated with Vitronectin (StemMACS iPS-Brew XF (Miltenyi), supplemented with 2uM Thiazovivin) and incubated overnight. On day − 1, cells were washed once in PBS and the medium was changed to fresh StemMACS iPS-Brew …
July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced the publication of preclinical research in the July 6 issue of Science Translational Medicine. The article, titled “Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse …
Dr. Jane
October 13, 2021
The award recognizes the research with the highest translational potential Translational medicine is an interdisciplinary branch in the biomedical field that aims to combine benchside, bedside and community to improve prevention, diagnosis and treatment Ingelheim, Germany, October 11, 2021 Boehringer Ingelheim, a global leader in animal health, presented its first biennial Translational Medicine Award during the North American Veterinary Regenerative …
– IM-250 reduces viral load, virus shedding and the rate of recurrence – Potential treatment for persistent, neurotrophic herpes simplex Munich, Germany, June 16, 2021 – Innovative Molecules GmbH, a drug development company focused on developing next generation treatments for herpes simplex-induced diseases, today announced preclinical data demonstrating that the company’s drug candidate IM-250 carries both acute and chronic infections …
